Camilla Appelgren

+46 (0) 70 278 72 10

Primary practices

Corporate, M&A, Commercial, Financing, Life Sciences


Swedish, English


Camilla Appelgren's main areas of practice are Life Sciences, Corporate, M&A and Finance. She has been involved in domestic and cross-border transactions within a number of different industries and regularly provides advice to publicly traded and privately held Swedish and international clients. Camilla has vast experience within the areas of health care, pharmaceuticals, food and medical devices and advices clients on a regularly basis in contract negotiations and regulatory matters. Camilla is also engaged as a speaker at seminars and conferences, and has written a number of articles within the life sciences area.


•Calissendorff Swarting, Partner (2015-)
• Setterwalls, Senior Associate (2009-2015), Associate (2006-2009)
• Holland & Knight LLP, New York, (2010)
• Stockholm District Court, law clerk (2004-2006)
• Secretary in the Stockholm ethical committee on animal research (2004-2006)


• Member of the Swedish Bar
• Member of the International Bar Association (IBA)


• Lund University, School of Economics and Management Bachelor of Science with a Major in Corporate Finance, (Civilekonom) (1999-2004)
• Lund University, Faculty of Law, Master of Law (L.L.M), (1998-2003)
• London School of Economics and Queen Mary, University of London, Studies in international financial and banking law (2001)


Swedish, English


• "Getting the Deal trough, Life Sciences", Swedish chapter 2012-2015
• "European transparency going live” - Life Sciences Report May 2015
• "Pricing and availability of pharmaceuticals" - Life Sciences Report May 2014
• "Listings increasing in the Life Sciences sector in 2014" - Life Sciences Report May 2014
• "Proposals for health and medical care in the central government budget for 2014", Life Sciences Report, November 2013
• "CROs in Sweden and the foundation of ASCRO", Life Sciences Report, May 2013
• "Bioavtion Park Telge", Life Sciences Report, May 2013
• "Stem cell research from a legal perspective", Life Sciences Report, May 2012
• "Due diligence in the Healthcare and Life Sciences industry", Life Sciences Report, May 2012
• "Appeal of TLVs and MPAs decisions and their immediate effect", Life Sciences Report, December 2011
• "A growing market for CROs and CMOs", Life Sciences Report, March 2011
• "Environmental issues in the Life Sciences industry", Life Sciences Report, March 2011
• "Global Reference Guide: Biotech & Pharmaceuticals”, Financier Worldwide, 2010